Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone and language demonstrate recognition of the review’s comprehensive analysis of pharmacological treatments, with references to randomized controlled trials and the potential effectiveness of testosterone-lowering drugs. Phrases like 'fifty years of trials' and 'empirical evidence' underscore a respectful engagement, while acknowledgment of the need for more research illustrates awareness of limitations. These elements collectively suggest a positive, engaged, and impactful reaction to the publication.
Most discussions acknowledge the review's findings that pharmacological treatments can reduce sexual activity in affected individuals, indicating general agreement on the article's conclusions.
Participants show moderate curiosity, referencing specific studies and emphasizing the need for further research, suggesting a genuine but cautious interest.
Posts mention empirical evidence, discuss trial evaluations, and highlight the significance of the review, reflecting active engagement with the material's methods and implications.
The discussions recognize that the review consolidates a large body of research over decades, highlighting its importance for future treatment approaches and policy considerations.
No stone left unturned when I and colleagues reviewed fifty years of pharmacological trials (RCTs) on pedophilic disorder and compulsive sexual behavior disorder. The paper is finally published
Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review | SpringerLink✅✅✅ https://t.co/FP2QJTTgWs
@sexywatermelon5 @j4x_qtx @br1ngth3pa1n Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review https://t.co/HYNoDMoVAI
RT @uOPsychiatry: A team led by Christoffer Rahm (@Priotab) including co-author Michael Seto (@MCSeto) review the evidence for the pharmaco…
RT @uOPsychiatry: A team led by Christoffer Rahm (@Priotab) including co-author Michael Seto (@MCSeto) review the evidence for the pharmaco…
RT @Priotab: No stone left unturned when I and colleagues reviewed fifty years of pharmacological trials (RCTs) on pedophilic disorder and…
This video reviews pharmacological treatments for pedophilic disorder and compulsive sexual behavior disorder, highlighting that current guidelines are mainly based on data from forensic settings and risk assessments…
This video discusses the issues within the US psychiatric system related to paraphilia, highlighting treatment challenges, prevalence, and the need for more research. It also reviews pharmacological approaches for…
@sexywatermelon5 @j4x_qtx @br1ngth3pa1n Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review https://t.co/HYNoDMoVAI
@bellamadison22 @DemonInkMerc @joakial_ The study is called "Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review" It was a review of randomized controlled trials of pharmacological treatment; empirical showed drugs reduce sexual activity for PeD or CSBD. 1/
@abaaacd @spectr1de @thisappisnotok @E_Knockk @MadzzzDraws @ThinkingMunk @TheOmniLiberal @mrGemzar @FBI https://t.co/5KOtUimK4L CBT (cognitive behavioral therapy) "significantly reduces hypersexuality" https://t.co/gAWysbHIGD "provide some empirical evidence that testosterone-lowering drugs reduce sexual activity for patients with PeD or CSBD" (but more research needed)
Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review | SpringerLink✅✅✅ https://t.co/FP2QJTTgWs
#compulsivesexualdisorder #pharmacologicaltreatment Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review https://t.co/s2c2FHEDxY
RT @uOPsychiatry: A team led by Christoffer Rahm (@Priotab) including co-author Michael Seto (@MCSeto) review the evidence for the pharmaco…
RT @uOPsychiatry: A team led by Christoffer Rahm (@Priotab) including co-author Michael Seto (@MCSeto) review the evidence for the pharmaco…
RT @uOPsychiatry: A team led by Christoffer Rahm (@Priotab) including co-author Michael Seto (@MCSeto) review the evidence for the pharmaco…
RT @Priotab: No stone left unturned when I and colleagues reviewed fifty years of pharmacological trials (RCTs) on pedophilic disorder and…
RT @Priotab: No stone left unturned when I and colleagues reviewed fifty years of pharmacological trials (RCTs) on pedophilic disorder and…
RT @Priotab: No stone left unturned when I and colleagues reviewed fifty years of pharmacological trials (RCTs) on pedophilic disorder and…
RT @Priotab: No stone left unturned when I and colleagues reviewed fifty years of pharmacological trials (RCTs) on pedophilic disorder and…
No stone left unturned when I and colleagues reviewed fifty years of pharmacological trials (RCTs) on pedophilic disorder and compulsive sexual behavior disorder. The paper is finally published